Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells

The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition

(2011) F. Rodel et al.   CURRENT MEDICINAL CHEMISTRY

Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma

(2011) Sebastian Reichert et al.   RADIOTHERAPY AND ONCOLOGY

Adsorption of obidoxime onto human serum albumin nanoparticles: Drug loading, particle size and drug release

(2010) Jürgen Kufleitner et al.   JOURNAL OF MICROENCAPSULATION

Enhanced drug targeting by attachment of an anti αv integrin antibody to doxorubicin loaded human serum albumin nanoparticles

(2009) Sylvia Wagner et al.   BIOMATERIALS

Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles

(2009) Xiuming Niu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

(2009) Anja Zensi et al.   JOURNAL OF CONTROLLED RELEASE

Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression

(2009) Isabel Steinhauser et al.   JOURNAL OF DRUG TARGETING

Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery

(2008) Sufeng Zhang et al.   BIOTECHNOLOGY PROGRESS

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE

Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation

(2007) K. Langer et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS